Literature DB >> 29206348

Perfusion-based fluorescence imaging method delineates diverse organs and identifies multifocal tumors using generic near-infrared molecular probes.

Jessica Miller1,2, Steven T Wang1, Inema Orukari1,2, Julie Prior1, Gail Sudlow1, Xinming Su3, Kexian Liang1, Rui Tang1, Elizabeth M C Hillman4, Katherine N Weilbaecher3, Joseph P Culver1,2, Mikhail Y Berezin1,5, Samuel Achilefu1,2,6.   

Abstract

Rapid detection of multifocal cancer without the use of complex imaging schemes will improve treatment outcomes. In this study, dynamic fluorescence imaging was used to harness differences in the perfusion kinetics of near-infrared (NIR) fluorescent dyes to visualize structural characteristics of different tissues. Using the hydrophobic nontumor-selective NIR dye cypate, and the hydrophilic dye LS288, a high tumor-to-background contrast was achieved, allowing the delineation of diverse tissue types while maintaining short imaging times. By clustering tissue types with similar perfusion properties, the dynamic fluorescence imaging method identified secondary tumor locations when only the primary tumor position was known, with a respective sensitivity and specificity of 0.97 and 0.75 for cypate, and 0.85 and 0.81 for LS288. Histological analysis suggests that the vasculature in the connective tissue that directly surrounds the tumor was a major factor for tumor identification through perfusion imaging. Although the hydrophobic dye showed higher specificity than the hydrophilic probe, use of other dyes with different physical and biological properties could further improve the accuracy of the dynamic imaging platform to identify multifocal tumors for potential use in real-time intraoperative procedures.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  basis function; cancer; molecular probe; near-infrared; optical

Mesh:

Substances:

Year:  2018        PMID: 29206348      PMCID: PMC5903995          DOI: 10.1002/jbio.201700232

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  30 in total

1.  In vivo molecular target assessment of matrix metalloproteinase inhibition.

Authors:  C Bremer; C H Tung; R Weissleder
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

2.  Monomolecular multimodal fluorescence-radioisotope imaging agents.

Authors:  Zongren Zhang; Kexian Liang; Sharon Bloch; Mikhail Berezin; Samuel Achilefu
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

3.  Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis.

Authors:  Eline E Deurloo; Johannes L Peterse; Emiel J Th Rutgers; Albert P E Besnard; Sara H Muller; Kenneth G A Gilhuijs
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

Review 4.  Image-guided cancer surgery using near-infrared fluorescence.

Authors:  Alexander L Vahrmeijer; Merlijn Hutteman; Joost R van der Vorst; Cornelis J H van de Velde; John V Frangioni
Journal:  Nat Rev Clin Oncol       Date:  2013-07-23       Impact factor: 66.675

5.  Heptamethine cyanine dyes with a robust C-C bond at the central position of the chromophore.

Authors:  Hyeran Lee; J Christian Mason; Samuel Achilefu
Journal:  J Org Chem       Date:  2006-09-29       Impact factor: 4.354

6.  First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study.

Authors:  Yang Liu; Yi-Ming Zhao; Walter Akers; Zhao-You Tang; Jia Fan; Hui-Chuan Sun; Qing-Hai Ye; Lu Wang; Samuel Achilefu
Journal:  Transl Res       Date:  2013-06-05       Impact factor: 7.012

7.  Rational approach to select small peptide molecular probes labeled with fluorescent cyanine dyes for in vivo optical imaging.

Authors:  Mikhail Y Berezin; Kevin Guo; Walter Akers; Joseph Livingston; Metasebya Solomon; Hyeran Lee; Kexian Liang; Anthony Agee; Samuel Achilefu
Journal:  Biochemistry       Date:  2011-03-08       Impact factor: 3.162

8.  Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.

Authors:  Melissa L Korb; Yolanda E Hartman; Joy Kovar; Kurt R Zinn; Kirby I Bland; Eben L Rosenthal
Journal:  J Surg Res       Date:  2013-11-22       Impact factor: 2.192

9.  Predicting in vivo fluorescence lifetime behavior of near-infrared fluorescent contrast agents using in vitro measurements.

Authors:  Walter J Akers; Mikhail Y Berezin; Hyeran Lee; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2008 Sep-Oct       Impact factor: 3.170

Review 10.  Why are tumour blood vessels abnormal and why is it important to know?

Authors:  J A Nagy; S-H Chang; A M Dvorak; H F Dvorak
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more
  1 in total

Review 1.  Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation.

Authors:  Madeline T Olson; Quan P Ly; Aaron M Mohs
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.